UNSPSC 51182078: Trenbolone acetate

This classification denotes an anabolic steroid with the molecular formula C20H24O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RUD5Y4SV0S, chemically known as 17beta-hydroxyestra-4,9,11-trien-3-one, acetate but more generally known as trenbolone acetate, which bears US NIH Compound Identifier 66359. European Medicines Agency schedules Trenbolone acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32683.

Most nations, for tariff and trade purposes, schedule trenbolone acetate under HS 29372900 and SITC 54153. As of Q4 2014, TRENBOLONE ACETATE remains US FDA's Preferred Term for this commodity. Trenbolone acetate bears US NLM identifiers UMLS ID C0076958 and NCI Concept Code C61982. SMILES: CC(=O)O[C@H]1CC[C@@H]2[C@@]1(C=CC3=C4CCC(=O)C=C4CC[C@@H]23)C.

UNSPSC 51182078 Trenbolone acetate is a Commodity code representing a controlled anabolic steroid used primarily in veterinary and animal agriculture applications. State and local government procurement under this code is minimal to nonexistent; the recent solicitation activity tagged to this code does not reflect purchases of trenbolone acetate itself. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP in January 2026 for generic multi-source pharmaceuticals and over-the-counter products, a broad therapeutic procurement that encompasses hundreds of distinct drugs and dosage forms across human and institutional health systems—a scope that bears no functional relationship to a single veterinary anabolic steroid. This mismatch suggests either a cataloging error in the source data or an automated tagging artifact. State and local procurement of trenbolone acetate as a standalone commodity does not appear in current activity.

The single recent opportunity under this code—MMCAP's RFP S1070000015802, due March 26, 2026—is a multi-state cooperative purchasing vehicle administered by the Minnesota Department of Administration's Office of State Procurement and serving participating state and local facilities across Minnesota, Oregon, and other member jurisdictions. The procurement targets pharmaceutical manufacturers capable of supplying products through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson) with cGMP and DSCSA compliance, EDI capability, and flexible net-price or WAC-minus pricing. Award is weighted 75 percent on price competitiveness, 10 percent on fixed pricing stability, and 15 percent on administrative compliance and capability. This opportunity does not represent active market demand for trenbolone acetate specifically; firms should monitor whether this code will continue to receive generic pharmaceutical solicitations or whether data correction will reassign the tag to a broader human or animal pharmaceutical family.